Medical Journals Refuse to Retract Fraudulent Trial Reports That Omitted Suicidal Events in Children
Mad in America
MARCH 21, 2024
We cited research based on the clinical study reports the manufactures had submitted to drug regulators to get their drugs approved for children and adolescents and other research in our letter. 4,5 I asked Emslie and the manufacturer, Eli Lilly, if they wanted to restore the trials. J Affect Disord 2022;305:55-64.
145 
Let's personalize your content